Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about AstraZeneca PLC

Recent news which mentions AstraZeneca PLC

< Previous 1 2 3 4 5 Next >
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags Viking Therapeutics Inc Companies AstraZeneca PLC
From CNBC.com News
Beijing pledges greater market access as top global CEOs gather at the China Development Forum
Tags Asia News Asia: Business Qualcomm Inc
From CNBC.com News
CNBC Daily Open: Tariff flexibility sounds good, but also signals uncertainty
Tags AstraZeneca PLC Daily Open Meta Platforms Inc
From CNBC.com News
British pharma giant AstraZeneca to invest $2.5 billion in new China hub
Tags Health care industry AstraZeneca PLC Europe News
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags GE HealthCare Technologies Inc Social issues Alphabet Inc
From CNBC.com News
CNBC's Inside India newsletter: A slowing economy hasn't dimmed India's allure at Davos
Tags Prices World Economy World Politics
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags GSK plc LILLY DRN US: News
From CNBC.com News
J&J says its lung cancer drug combination keeps people alive longer
Tags Johnson & Johnson Health & Science Health care industry
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags Pfizer Inc Health care industry AstraZeneca PLC
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Health & Science LILLY DRN Bristol/Myers Squibb Co
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Pfizer Inc Home Depot Inc AstraZeneca PLC
From CNBC.com News
Cramer's Lighting Round: 'I'm not going to recommend' Altria
Tags Becton Dickinson and Co Investment Strategy AstraZeneca PLC
From CNBC.com News
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
Tags Healthy Returns Social issues Health & Science
From CNBC.com News
The 2 things that will drive the stock market after last week's Trump-Fed rally
Tags Investing Wells Fargo & Co Wall Street
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags LILLY DRN Social issues Health & Science
From CNBC.com News
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Tags Biotechnology Business Health & Science
From CNBC.com News
Cerebras IPO has 'too much hair' as AI chipmaker tries to sell Wall Street on Nvidia alternative
Tags Business NVIDIA Corp GlaxoSmithKline Pharmaceuticals Ltd
From CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
Tags Health care industry Eli Lilly and Co Bristol/Myers Squibb Co
From CNBC.com News
AstraZeneca shares fall 5% on disappointing lung cancer drug trial results
Tags Companies Health & Science Health care industry
From CNBC.com News
AstraZeneca says staff detained in China amid reports of a drug-import investigation
Tags Business News Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
India and Singapore agree to cooperate on chips as countries seek to strengthen partnership
Tags International relations Apple Inc AstraZeneca PLC
From CNBC.com News
India's Modi expected to usher in new era of bilateral agreements in Singapore visit
Tags Apple Inc Breaking News: Technology Asia Economy
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Novo Nordisk A/S Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Merck & Co Inc Bristol/Myers Squibb Co Health & Science
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Tags Biotech and Pharmaceuticals Johnson & Johnson Science
From CNBC.com News
Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030
Tickers CEO
Tags Investment Strategy U/S/ Markets AstraZeneca PLC
From CNBC.com News
Cramer's Lighting Round: 'You've got a winner' with Astra Zeneca
Tags Stock Picks stocks Business News
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Tags Investment strategy Breaking News: Investing Health care industry
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags Health care industry AstraZeneca PLC World News
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Biotechnology Business Health & Science
From CNBC.com News
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.